Latest News for Clearwave Stock (OTC:CWTC)

Clearwave Telecommunications Inc is engaged in providing wholesale and corporate telecommunications infrastructure service. It deploys fibre optic and air fibre networks, throughout the Caribbean and South America.

News

Intraday Update

Markets

Movers

Trading Ideas

ALLE

AMKR

AMRR

ATBPF

ATEC

BDSI

BEVVF

BPYPP

BUKS

CODI

CROX

CWTC

CXKJ

DOOR

EPIX

FITBO

FLOW

FMBV

GNBT

GPIW

GRMN

HURN

IMXI

IPHI

ISEE

KBLM

KFRC

MFSF

MGRC

NBTB

NSIT

NUAN

PDFS

PRFT

PSMT

QALB

QCRH

RDCM

REPH

RETA

REXR

RLBY

RPAI

SHOO

SITC

SITE

SLGX

TMEB

TRNS

TRRSF

VNWTF

VRTX

WTBA

SLFYF

ELEEF

CMCL

FBAYF

IMMB

Stocks That Hit 52-Week Highs On Wednesday

AAPL

AGAAF

AGYS

ALGT

AMAT

AMWD

ANIK

ARMK

BASI

BERI

BRKS

CAGDF

CBSH

CCBG

CGIX

CHDN

CHTR

CLBK

CMPR

COWP

COWPP

CPRT

CUBI

DMKBA

New Oriental Education & Technology Group

EGRX

EPRT

ESGRO

ESNT

FBHS

FBPRM

FORM

FRTA

FSBW

FWRD

GLIBA

GNRC

GNTY

GOODN

HEES

HTLD

ICHR

INXN

IRCC

KDCE

KLAC

LAWS

LBRDA

LBRDB

LBRDK

LECO

LEN-B

LRCX

LSXMA

MAIFF

MGDPF

MKSI

MLRKF

MOBO

MRTN

Stocks That Hit 52-Week Highs On Friday

AEMD

ANSS

ARVY

BLDR

BMCH

CMRE

DTST

ESGRP

FRHC

GTSIF

HMCBF

INRD

KNSL

LULU

MCDMF

NFBK

NTRA

NXRT

PPIH

PTSI

RLMD

SPAR

TMHC

TRBX

VIVC

VNCE

WODI

SHPNF

AGCCF

SNVFF

NATUF

Stocks That Hit 52-Week Highs On Tuesday

CLEARWAVE TELECOMM INC by Clearwave Telecommunications, Inc.

Clearwave Telecommunications Inc

Ashford Hospitality Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) ("Ashford Trust" or the "Company") today announced its preliminary expectations for net income attributable to common stockholders, Adjusted EBITDAre, and Adjusted FFO for the first quarter ended March 31, 2024.
The Company reported today a preliminary estimated range of net income attributable to common stockholders of approximately $66.4 million to $68.4 million or $0.59 to $0.61 per share, a preliminary estimated range of Adjusted EBITDAre of $58.5 million to $60.5 million, and a preliminary estimated range of Adjusted FFO available to common stockholders and OP unitholders of $(14.7) million to $(12.7) million for the first quarter ended March 31, 2024. Final results for the first quarter ended March 31, 2024 will be released on May 7, 2024, as previously announced.
We use certain non-GAAP measures, in addition to the required GAAP presentations, as we believe these measures improve the understanding of our operational results and make comparisons of operating results among peer real estate investment trusts more meaningful. Non-GAAP financial measures used in this press release, which should not be relied upon as a substitute for GAAP measures, are FFO, AFFO, EBITDA, EBITDAre and Adjusted EBITDAre. Please refer to our most recently filed Annual Report on Form 10-K for a more detailed description of how these non-GAAP measures are calculated. The reconciliations of non-GAAP measures to the closest GAAP measures are provided below and provide further details of our results for the periods being reported.
The following tables are reconciliations of the Company's preliminary estimated GAAP net income (loss) to the Company's preliminary estimated EBITDA, EBITDAre, Adjusted EBITDAre, FFO and Adjusted FFO:

Earnings

Guidance

Ashford Hospitality Trust Reports Preliminary Estimated Range Of Net Income ~$66.4M-$68.4M Or $0.59-$0.61 Per Share; EBITDAre Of $58.5M-$60.5M; Adj FFO $(14.7)M-$(12.7)M For Q1 Ended March 31, 2024. Final Results For Q1 Will Be Released On May 7, 2024

In a historic trading session on Tuesday, cannabis stocks soared following the <a href="https://www.benzinga.com/markets/cannabis/24/04/38530190/breaking-dea-reportedly-moves-to-reschedule-cannabis-stocks-rise-sharply-on-the-news">DEA&#39;s reported decision to reclassify marijuana</a> from Schedule I to Schedule III under the Controlled Substances Act.
This regulatory shift, which would align with a recommendation from the Department of Health and Human Services,<a href="https://www.benzinga.com/markets/cannabis/24/04/38531355/cannabis-stocks-and-etfs-surge-as-dea-moves-to-reschedule-marijuana">&nbsp;sparked investor interest</a>.
evidenced by gains in major cannabis stocks on the NASDAQ.
Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) led the gains, skyrocketing by 78.8% to close at $14.88 per share amid a trading frenzy that pushed the volume to 79.25 million shares.
Aurora Cannabis (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acb#NASDAQ">ACB</a>) wasn&#39;t far behind, climbing 46% to close at $9.23 per share with a volume of 37.921 million shares. Tilray Brands Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>) also enjoyed an upswing, rising 39.5% to end the day at $2.47 per share with a volume of 147.306 million shares.
WM Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/maps#NASDAQ">MAPS</a>) saw a moderate increase of 1.44%, closing at $1.06 per share, with trading volume reaching 4.428 million shares.
The sudden uptick in these stocks highlights the market&#39;s optimistic reaction to the DEA&#39;s policy change, but when placed in the context of the year&#39;s performance, the perspective shifts slightly.
<h3>A Rocky Road</h3>
Aurora Cannabis, for example, experienced a robust recovery from its earlier slump in January, climbing 43.96% from its low in April before the most recent jump of 46%. Similarly, Canopy Growth Corporation managed a striking rally of 162.31% in March, despite a slight dip in April, culminating in an extraordinary single-day surge of 78.8%.
These fluctuations underscore a pattern of high volatility, suggesting that while the upsurges are significant, they are part of broader, unstable trading patterns that have characterized these stocks throughout the year.
Conversely, stocks like Tilray and WM Technology, Inc. have also shown significant swings, with Tilray rising 42.77% in March only to fall again in April&nbsp;and MAPS experiencing a decline of 21.43% after a strong gain.
These movements indicate that while the DEA&#39;s recent policy change has indeed injected a dose of optimism into the market, the broader year&#39;s perspective reveals fluctuating valuations.&nbsp;
Pro tip: Learn all about the future of the cannabis industry at the Benzinga Cannabis Capital Conference this October in Chicago. Hear directly from key industry players and policymakers. Get your tickets now by following&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noopener noreferrer" target="_blank">this link</a>, and access a 20% discount using the code JAVI20.
<h3>Stock Performance In The Last Quarter</h3>
In the third quarter, Aurora <a href="https://www.benzinga.com/markets/cannabis/24/02/37011868/aurora-touts-41-yoy-increase-in-international-medical-cannabis-q3-revenue-expands-in-australia-v">reported</a> a modest rise in net revenue to CA$64.4 million ($68.7 million), up from CA$61.1 million in the same quarter last year, and growth in its medical marijuana segment, which saw a 16% increase to CA$45.1 million.
Tilray Brands showed a <a href="https://www.benzinga.com/markets/cannabis/24/04/38160302/cannabis-giant-tilray-reports-30-yoy-increase-in-q3-net-revenue-updates-fy-2024-guidance">stronger performance</a>&nbsp;with third-quarter net revenue jumping 30% year-over-year to $188.3 million with its adjusted gross profit improving by 17% to $51.6 million.
Conversely, Canopy Growth presented a <a href="https://www.benzinga.com/markets/cannabis/24/02/37034521/canopy-growth-reports-7-yoy-drop-in-q3-revenue-ceo-touts-new-era-for-company-as-it-seeks-us-list">mixed financial picture</a>, noting an 81% increase in its &ldquo;rest-of-world&rdquo; cannabis revenue, which reached CA$10.5 million. Yet&nbsp;its core Canadian cannabis segment experienced a decline, with net revenue falling from CA$46.6 million in the prior year&#39;s quarter&nbsp;to CA$39 million.&nbsp;
<h3>What Happens Next?</h3>
As the DEA proposes reclassifying cannabis from Schedule I to Schedule III, the Marijuana Policy Project <a href="https://www.benzinga.com/markets/cannabis/24/04/38531267/marijuana-policy-project-reacts-with-scepticism-to-deas-proposal-to-reschedule-cannabis">noted </a>the limited impact this change has on the criminalization of cannabis users under state laws and advocates for more robust state-level initiatives for comprehensive cannabis legalization and fair medical laws.
The U.S. Cannabis Council, through its executive director Edward Conklin, <a href="https://www.benzinga.com/markets/cannabis/24/04/38531182/us-cannabis-council-call-dea-historic-decision-to-reclassify-cannabis-a-tectonic-shift">described</a> the DEA&#39;s decision as a &quot;tectonic shift&quot; in drug policy, emphasizing the economic and social benefits expected from moving cannabis to Schedule III, including potentially ending the restrictive 280e&nbsp;tax penalty.
In a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38226873/analyst-reacts-to-fda-commish-comments-medical-and-recreational-cannabis-could-have">recent report</a>, senior analyst Pablo Zuanic suggested the rescheduling&nbsp;of cannabis could focus primarily on medical cannabis, which could allow for more controlled and supported medical use under federal guidelines.
This would enable better research, development&nbsp;and medical application of cannabis, enhancing its legitimacy and accessibility as a therapeutic substance.
<h3>Who Wins With Rescheduling?</h3>
The rescheduling of cannabis carries implications for <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33482140/rescheduling-cannabis-what-are-the-implications-for-msos-tax-rule-280e-fda-and-phar">various stakeholders within the industry</a>, including multistate operators, pharmaceutical companies&nbsp;and federal regulatory bodies like the FDA.
Removing <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33482521/curaleaf-and-trulieve-lead-the-pack-in-tax-payments-a-look-at-16-cannabis-msos-liab">Tax Rule 280E </a>could increase profitability for U.S. cannabis businesses by lowering their effective tax rates, which have been notably high. This advantage is balanced by the introduction of potential FDA oversight and the entry of pharmaceutical companies into the market.
This transition could render cannabis federally legal under certain schedules, increasing regulatory requirements and altering the competitive landscape by enabling pharmaceutical entities to potentially dominate, especially in the medical cannabis segment.
The reduction of the 280E tax burden would provide financial relief but also bring the risk of enhanced regulation and operational challenges. Zuanic also points out that MSOs might see <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/08/34153665/cannabis-tax-changes-could-trigger-504-cash-flow-leap-which-industry-players-will-b">improvements in cash flow management</a> and tax reductions.&nbsp;
Photo: AI-Generated Image.&nbsp;

Analyst Color

Cannabis

Government

Regulations

Politics

Legal

Analyst Ratings

MAPS

TLRY

Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady

The battle between Donald Trump and Joe Biden for the White House is nearing the six-month mark for voters to decide which candidate will win the<a href="https://www.benzinga.com/topic/2024-election"> 2024 election on Nov. 5, 2024.</a>
A new poll shows how voters in key swing states would vote today.
What Happened: Many<a href="https://www.benzinga.com/topic/election-poll"> election polls </a>point to a close race between Biden and Trump in the 2024 election, an event that could be a rematch of the 2020 presidential election won by Biden.
A new Emerson College poll shows how voters in key swing states would vote in a head-to-head matchup of Trump and Biden and also how they would vote when the two candidates face off against key third-party candidate Robert F. Kennedy Jr.
Here are the results for the head-to-head <a href="https://emersoncollegepolling.com/trump-holds-edge-over-biden-in-seven-key-swing-state-polls/">poll</a>:
Arizona: 44% Biden, 48% Trump, 8% Undecided
Georgia: 44% Biden, 47% Trump, 9% Undecided
Michigan: 44% Biden, 45% Trump, 11% Undecided
Nevada: 44% Biden, 45% Trump, 11% Undecided
North Carolina: 42% Biden, 47% Trump, 10% Undecided
Pennsylvania: 45% Biden, 47% Trump, 8% Undecided
Wisconsin: 45% Biden, 47% Trump, 8% Undecided
The poll shows Trump winning all seven states in the head-to-head matchup against Biden. Trump's lead is only one point in several states.
"The share of undecided voters has reduced and Biden gained ground in Georgia and Nevada, narrowing the gap, while Trump has maintained a slight edge on Biden in Pennsylvania and Wisconsin," Emerson College Polling executive director Spencer Kimball said.
Here are the results of the poll when Robert F. Kennedy and other candidates are considered. The remaining percentage for each state went to other or undecided.
Arizona: 40% Biden, 44% Trump, 9% Kennedy Jr.
Georgia: 39% Biden, 45% Trump, 5% Kennedy Jr.
Michigan: 42% Biden, 43% Trump, 5% Kennedy Jr.
Nevada: 37% Biden, 42% Trump, 8% Kennedy Jr.
North Carolina: 37% Biden, 46% Trump, 6% Kennedy Jr.
Pennsylvania: 41% Biden, 45% Trump, 6% Kennedy Jr.
Wisconsin: 40% Biden, 45% Trump, 6% Kennedy Jr.
When third-party candidates are included for voters, Biden loses more support than Trump in five states. Two states (Arizona, Michigan) see both Biden and Trump lose the same amount of support.
Related Link: <a href="https://www.benzinga.com/general/politics/24/04/38348604/biden-vs-trump-new-poll-shows-tie-in-2024-election-race-one-candidate-gains-among-independent-vo">Biden Vs. Trump: New Poll Shows Tie In 2024 Election Race, One Candidate Gains Among Independent Voters</a>
Why It's Important: The poll results show Trump with a lead in all states in head-to-head and with other candidates to choose from.
The poll also found that Independent voters favored Trump over Biden in five of the swing states with Biden winning in Georgia and Wisconsin. Biden also led Trump in the states of Michigan, Pennsylvania and Wisconsin among voters who are members of labor unions.
The other bad news for Biden was the poll asking voters about the <a href="https://www.benzinga.com/general/politics/24/04/38326553/trump-hush-money-trial-has-12-jurors-here-are-the-7-men-5-women-to-decide-former-presidents-fate">criminal case against Trump</a> alleging hush money payments. The poll found that voters in six of the seven states said they were more likely to support Trump if he's found guilty in the case versus the number of voters who said they were less likely to support Trump.
The <a href="https://www.benzinga.com/general/politics/24/03/37884006/trump-vs-biden-key-swing-states-arizona-nevada-michigan-wisconsin-show-close-races-heres-the-rol" target="_blank" rel="noreferrer noopener">seven swing states </a>together represent 93 electoral votes in the 2024 election. Six of the seven swing states were won by Biden in the 2020 election, with Trump winning North Carolina. Five of the seven swing states won by Biden in 2020 flipped from Trump&#8217;s win in 2016, including Arizona, Michigan and Wisconsin.
While the 2024 election is months away, recent polls of voters in swing states have not shown favorable results for Biden, which could be worrisome for his campaign.
Read Next: <a href="https://www.benzinga.com/general/politics/24/04/38523639/judge-threatens-trump-with-incarceration-fines-him-for-violating-gag-order-jail-may-be-a-necessa">Judge Threatens Trump With Incarceration, Fines Him For Violating Gag Order: &#8216;Jail May Be A Necessary Punishment&#8217;</a>
Photos: Shutterstock

Trump Vs. Biden: Former President Holds Lead In All 7 Swing States, Which Candidate Does Robert F. Kennedy Jr. Hurt More?

Huron Consulting Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HURN#NASDAQ">HURN</a>) reported quarterly earnings of $1.23 per share which beat the analyst consensus estimate of $0.89 by 38.2 percent. This is a 41.38 percent increase over earnings of $0.87 per share from the same period last year. The company reported quarterly sales of $355.961 million which beat the analyst consensus estimate of $351.014 million by 1.41 percent. This is a 11.97 percent increase over sales of $317.895 million the same period last year.

Earnings Beats

Huron Consulting Gr Q1 2024 Adj EPS $1.23 Beats $0.89 Estimate, Sales $355.961M Beat $351.014M Estimate

Investors who bought leading cryptocurrency Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) years ago likely enjoyed a strong 2024 that saw the approval of Bitcoin ETFs and new all-time highs reached on several occasions <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37498047/exclusive-bitcoin-hits-new-all-time-high-heres-when-benzinga-readers-think-100k-milestone-#:~:text=While%20the%20all%2Dtime%20high,52%2Dweek%20high%20of%20%2468%2C789.63.">in March.</a>
A YouTuber begged people to put $1 into Bitcoin in a video shared on May 9, 2013. Here's a look back at the video and how much viewers could have made following his advice.
What Happened: YouTuber Davinci Jeremie launched several videos about Bitcoin prior to 2013, including those calling for viewers to<a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38041549/trader-who-urged-everyone-to-buy-1-of-bitcoin-in-2013-now-advocates-for-dogecoin-killer-sh"> buy $1 in Bitcoin.</a>
His most famous video was one from May 9, 2013, titled "Bitcoin update – just buy $1 worth of bitcoin please!"
In the <a href="https://www.youtube.com/watch?v=Cw29h7LhEuE">video</a>, Jeremie told viewers Bitcoin "is more than just a payment system." The YouTuber praised Bitcoin creator Satoshi Nakamoto in the video and said the cryptocurrency could remain free and open and accomplish many things in the future.
"It is a freedom provider for the rest of humanity," Jeremie said.
Jeremie recognized many viewers were skeptical of Bitcoin, but he suggested investing a small amount of money and putting it into Bitcoin, then placing the investment aside for years.
"I suggest you take one fricking dollar, one dollar, buy some Bitcoins."
The YouTuber said it's just a dollar so if the investment goes to zero, you're not out much.
"It's just a dollar, get some Bitcoins."
Jeremie said he knew most viewers wouldn't take his advice.
"You're going to be thanking me."
Fast forward to 2024 and listening to Jeremie's advice could have netted huge returns for anyone who listened to his YouTube video.
Bitcoin traded between $109.60 and $115.78 on May 9, 2013, the date the video aired on YouTube, according to data from <a href="https://www.statmuse.com/money/ask/bitcoin-price-may-2013">Statmuse</a>. 
Investing $1 at the time could have purchased 0.0086 Bitcoin based on the day's high price. Today that $1 investment would be worth $516.26 based on a price of $60,029.90 for Bitcoin at the time of writing.
This marks an incredible return of 51,526% over the past 11 years.
Investors who felt more risky and invested $1,000 could have turned their investment into $518,484.25 over the past 11 years.
Related Link: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37381457/if-you-bought-1-worth-of-bitcoin-at-launch-heres-how-much-youd-have-today">If You Bought $1 Worth Of Bitcoin At Launch, Here&#8217;s How Much You&#8217;d Have Today</a>
Why It's Important: While it may be easy to look back at Jeremie's advice today and celebrate it at the time cryptocurrency was still considered a risky trade to many.
The key to Jeremie's video was the relative small investment amount he proposed. In the video description he mentioned buying Bitcoin "for the price of a lotto ticket" and holding it for 10 years.
The hypothetical investment illustrates how a small investment can grow over time. The small amount also shows the risk/reward profile illustrated by Jeremie who told viewers that if Bitcoin went to $0 they were only out the $1 they put into the cryptocurrency.
Jeremie has grown his following on YouTube to 519,000 <a href="https://www.youtube.com/channel/UCP0g6ygQkYjmog801YnNqtQ">subscribers </a>thanks to his previous call on Bitcoin. The content creator also has over 600,000 followers on <a href="https://www.instagram.com/davincij15/?hl=en">Instagram</a>.
Benzinga recently wrote that Jeremie has been advocating for Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) when asked by followers about the meme coin.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36462666/if-you-invested-1-000-in-bitcoin-at-the-last-bitcoin-halving-heres-how-much-youd-have-toda">If You Invested $1,000 In Bitcoin At The Last Bitcoin Halving, Here&#8217;s How Much You&#8217;d Have Today</a>
Photo: <a href="https://www.shutterstock.com/g/Mc_Cloud">Mc_Cloud</a> via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Education

$BTC

$SHIB

If You Invested $1 In Bitcoin When YouTuber Said 'One Dollar, Buy Some Bitcoins,' Here's How Much You'd Have Today

OPGN

UPDATE: OpGen deal was announced Monday.

Euro Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLWT#NASDAQ">CLWT</a>) reported quarterly earnings of $0.24 per share. This is a 380 percent increase over earnings of $0.05 per share from the same period last year. The company reported $17.94 million in sales this quarter. This is a 20.01 percent increase over sales of $14.95 million the same period last year.

CLWT

Euro Tech Hldgs FY EPS $0.24 Up From $0.05 YoY, Sales $17.94M Up From $14.95M YoY

WIIM

Viant Technology shares are trading higher after the company announced better-than-expected Q1 results and authorized a repurchase program.

Asset Sales

PG&E Comments In Emailed Statement, Sees Deal With KKR Cutting Rates By $100M+ Over Next 20 Years; Would Remain Majority Owner Of Pacific Generation

LMND

Lemonade shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY24 revenue guidance above estimates.

POAI

Predictive Oncology shares are trading higher after the company announced a collaboration with FluGen for an intranasal flu vaccine.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Clearwave Stock (OTC:CWTC)

Wednesday, October 30, 2019

Friday, October 25, 2019

Tuesday, October 15, 2019

Thursday, June 07, 2018